DeepCyte Raises $1.5M to Bring Single-Cell AI Toxicology to Drug Development

B WILMINGTON, Del. and COPENHAGEN, Denmark, April 9, 2026 /PRNewswire/ — DeepCyte, a techbio company building AI toxicology tools for drug development, launched today with $1.5…
posteditor
posteditor
Articles: 16137

Other News